1082 related articles for article (PubMed ID: 19433688)
21. A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia.
Weiss MA; Aliff TB; Tallman MS; Frankel SR; Kalaycio ME; Maslak PG; Jurcic JG; Scheinberg DA; Roma TE
Cancer; 2002 Aug; 95(3):581-7. PubMed ID: 12209751
[TBL] [Abstract][Full Text] [Related]
22. [Allogeneic bone marrow transplantation in children with acute lymphoblastic leukemia].
Maldonado MS; Otheo de Tejada E; Muñoz Villa A; García Laraña J
Sangre (Barc); 1993 Feb; 38(1):13-6. PubMed ID: 8470031
[TBL] [Abstract][Full Text] [Related]
23. [The results of treatment by the Madrid Pediatric Oncology Group according to the BFM protocols in non-Hodgkin's B-cell lymphoma and acute B-cell lymphoblastic leukemia in pediatric patients].
Vivanco Martínez JL; García Gscheidle A; Cela de Julián ME; Torres Valdivieso MJ; Melero Moreno C; López Pérez J; Contra Gómez T; Martín Ramos N; Díaz Pérez MA; Bernácer Borja M; Gil López C; Valverde Moreno F
An Esp Pediatr; 1996 Jan; 44(1):11-6. PubMed ID: 8849052
[TBL] [Abstract][Full Text] [Related]
24. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse.
Miglino M; Berisso G; Grasso R; Canepa L; Clavio M; Pierri I; Pietrasanta D; Gatto S; Varaldo R; Ballerini F; Verdiani S; Casarino L; DeStefano F; Sessarego M; Dominietto A; Raiola AM; Bregante S; di Grazia C; Gobbi M; Bacigalupo A
Bone Marrow Transplant; 2002 Nov; 30(9):579-85. PubMed ID: 12407432
[TBL] [Abstract][Full Text] [Related]
26. [Hematopoietic stem cell transplantation with busulfanthiotepa-cyclophosphamide conditioning for pediatric patients with high-risk acute lymphoblastic leukemia].
Umeda K; Lin YW; Watanabe K; Adachi S; Usami I; Akiyama Y; Kubota M; Nakahata T
Rinsho Ketsueki; 2001 Sep; 42(9):685-90. PubMed ID: 11680979
[TBL] [Abstract][Full Text] [Related]
27. Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission.
Dini G; Valsecchi MG; Micalizzi C; Busca A; Balduzzi A; Arcese W; Cesaro S; Prete A; Rabusin M; Mazzolari E; Di Bartolomeo P; Sacchi N; Pession A; Giorgiani G; Lanino E; Lamparelli T; Favre C; Bosi A; Manzitti C; Galimberti S; Locatelli F
Bone Marrow Transplant; 2003 Aug; 32(3):325-31. PubMed ID: 12858206
[TBL] [Abstract][Full Text] [Related]
28. Acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group (ALL-REZ BFM) experience: early treatment intensity makes the difference.
Herold R; von Stackelberg A; Hartmann R; Eisenreich B; Henze G
J Clin Oncol; 2004 Feb; 22(3):569-70; author reply 570-1. PubMed ID: 14752084
[No Abstract] [Full Text] [Related]
29. Prompt initiation of immunotherapy in children with an increasing number of autologous cells after allogeneic HCT can induce complete donor-type chimerism: a report of 14 children.
Gorczyñska E; Turkiewicz D; Toporski J; Kalwak K; Rybka B; Ryczan R; Sajewicz L; Chybicka A
Bone Marrow Transplant; 2004 Jan; 33(2):211-7. PubMed ID: 14628077
[TBL] [Abstract][Full Text] [Related]
30. Increasing risk of relapse after allogeneic stem cell transplant for adult acute lymphoblastic leukemia in > or = 2nd complete remission induced by highly intensive chemotherapy.
Mengarelli A; Iori AP; Cerretti R; Cerilli L; Romano A; Arcese W
Haematologica; 2002 Jul; 87(7):782-4. PubMed ID: 12091136
[TBL] [Abstract][Full Text] [Related]
31. The incidence of testicular recurrence in boys with acute leukemia treated with total body and testicular irradiation and stem cell transplantation.
Quaranta BP; Halperin EC; Kurtzberg J; Clough R; Martin PL
Cancer; 2004 Aug; 101(4):845-50. PubMed ID: 15305418
[TBL] [Abstract][Full Text] [Related]
32. Influence of transplantation regimen on prognostic significance of high-level minimal residual disease before allogeneic stem cell transplantation in children with ALL.
Schneider M; Hettinger K; Matthes-Martin S; Konrad M; Peters C; Gadner H; Panzer-Grümayer ER
Bone Marrow Transplant; 2001 Dec; 28(11):1087-9. PubMed ID: 11781621
[TBL] [Abstract][Full Text] [Related]
33. Treatment outcome of adolescents with acute lymphoblastic leukemia.
Irken G; Oren H; Gülen H; Duman M; Uçar C; Atabay B; Yilmaz S; Uysal K; Cevik N
Ann Hematol; 2002 Nov; 81(11):641-5. PubMed ID: 12454702
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Sharathkumar A; Saunders EF; Dror Y; Grant R; Greenberg M; Weitzman S; Chan H; Calderwood S; Freedman MH; Doyle J
Bone Marrow Transplant; 2004 Jan; 33(1):39-45. PubMed ID: 14566329
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients Labar B; Suciu S; Zittoun R; Muus P; Marie JP; Fillet G; Peetermans M; Stryckmans P; Willemze R; Feremans W; Jaksic B; Bourhis JH; Burghouts JP; de Witte T;
Haematologica; 2004 Jul; 89(7):809-17. PubMed ID: 15257932
[TBL] [Abstract][Full Text] [Related]
36. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?
Bader P; Kreyenberg H; Hoelle W; Dueckers G; Handgretinger R; Lang P; Kremens B; Dilloo D; Sykora KW; Schrappe M; Niemeyer C; Von Stackelberg A; Gruhn B; Henze G; Greil J; Niethammer D; Dietz K; Beck JF; Klingebiel T
J Clin Oncol; 2004 May; 22(9):1696-705. PubMed ID: 15117992
[TBL] [Abstract][Full Text] [Related]
37. Acute lymphoblastic leukemia in the elderly: The Edouard Herriot Hospital experience.
Thomas X; Olteanu N; Charrin C; Lhéritier V; Magaud JP; Fiere D
Am J Hematol; 2001 Jun; 67(2):73-83. PubMed ID: 11343378
[TBL] [Abstract][Full Text] [Related]
38. Treatment results of childhood acute lymphoblastic leukemia in Austria--a report of 20 years' experience.
Attarbaschi A; Mann G; Dworzak M; Urban C; Fink FM; Dieckmann K; Riehm H; Gadner H;
Wien Klin Wochenschr; 2002 Feb; 114(4):148-57. PubMed ID: 12060981
[TBL] [Abstract][Full Text] [Related]
39. The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse.
Unal S; Yetgin S; Cetin M; Gümrük F; Arslan D; Ozyürek E; Tuncer M; Topçu M
Pediatr Hematol Oncol; 2004; 21(3):279-89. PubMed ID: 15202168
[TBL] [Abstract][Full Text] [Related]
40. Treatment of children and adolescents with non-Hodgkin's lymphoma (results based on the NHL Berlin-Frankfurt-Münster 90 protocols).
Kavan P; Kabicková E; Gajdos P; Koutecký J; Smelhaus V; Stanková J; McClain KL
Cas Lek Cesk; 1999 Jan; 138(2):40-6. PubMed ID: 10376402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
